Prevalence and Risk Factors of Osteoporosis in Patients with Type 2 Diabetes Mellitus in Nanchang (China): A Retrospective Cohort Study

被引:17
作者
Li, Ting [1 ]
Hu, Ling [1 ]
Yin, Xiao-Ling [1 ]
Zou, Yi [1 ]
Fu, Hai-Yan [1 ]
Li, Hong-Lin [2 ]
机构
[1] Nanchang Univ, Dept Endocrinol, Hosp Nanchang 1, Affiliated Hosp 3, 28 Xiangshan North Rd, Nanchang 330008, Jiangxi, Peoples R China
[2] Med Coll Georgia, Dept Biochem, Augusta, GA USA
关键词
type 2 diabetes mellitus; osteoporosis; risk-factors; prevalence; FRACTURE RISK; DIFFERENTIATION; CELLS; WOMEN;
D O I
10.2147/DMSO.S372348
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To retrospectively review the clinical data of type 2 diabetes mellitus (T2DM) patients hospitalized in Nanchang, China, summarized the prevalence of osteoporosis (OP) in T2DM patients in this area, and analyzed related influencing factors.Methods: The clinical data of hospitalized patients with T2DM were collected retrospectively. According to the results of bone mineral density test, the subjects were divided into the normal bone mass group, the osteopenia group, and the OP group. Age, gender, educational background, body mass index (BMI), waist-to-hip ratio (WHR), duration of T2DM, glycosylated hemoglobin, serum lipids, and complications of T2DM in the three groups were analyzed and compared.Results: The prevalence of OP in patients with T2DM was 35.77%. There were statistically significant differences in age, gender, BMI, WHR, duration of T2DM, educational background, the level of high-density lipoprotein cholesterol (HDL-C), the prevalence of diabetic retinopathy (DR), and diabetic peripheral neuropathy among the three groups (P < 0.05). Logistic regression analysis showed that increasing age, prolonged duration of T2DM, low BMI, high levels of HDL-C, and complicated DR were risk factors for osteopenia and OP.Conclusion: The prevalence of OP in T2DM was high. Risk factors for abnormal bone mass in T2DM might be females, advanced age, long duration of T2DM, low BMI, high levels of HDL-C, and diabetic microangiopathy.
引用
收藏
页码:3039 / 3048
页数:10
相关论文
共 34 条
[1]   Features of the metabolic syndrome and the risk of non-vertebral fractures: The Tromso study [J].
Ahmed, LA ;
Schirmer, H ;
Berntsen, GK ;
Fonnebo, V ;
Joakimsen, RMJ .
OSTEOPOROSIS INTERNATIONAL, 2006, 17 (03) :426-432
[2]   Microvascular complications in diabetes: A growing concern for cardiologists [J].
Avogaro, Angelo ;
Fadini, Gian Paolo .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 291 :29-35
[3]   Peripheral Neuropathy as a Component of Skeletal Disease in Diabetes [J].
Beeve, Alec T. ;
Brazill, Jennifer M. ;
Scheller, Erica L. .
CURRENT OSTEOPOROSIS REPORTS, 2019, 17 (05) :256-269
[4]   The increase of neuropathic symptoms in diabetic patients is related with osteopenia [J].
Borekci, Elif ;
Kara, Adem ;
Kilic, Mahmut ;
Tanik, Nermin ;
Ozan, Zeynep T. ;
Yildirim, Tekin ;
Aral, Yalcin .
NEUROLOGICAL SCIENCES, 2021, 42 (07) :2873-2880
[5]   Advanced glycation end products induced IL-6 and VEGF-A production and apoptosis in osteocyte-like MLO-Y4 cells by activating RAGE and ERK1/2, P38 and STAT3 signalling pathways [J].
Chen, Helin ;
Liu, Wenjia ;
Wu, Xiangnan ;
Gou, Min ;
Shen, Jiefei ;
Wang, Hang .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 52 :143-149
[6]   Prevalence of osteoporosis in China: a meta-analysis and systematic review [J].
Chen, Peng ;
Li, Zhanzhan ;
Hu, Yihe .
BMC PUBLIC HEALTH, 2016, 16 :1-11
[7]  
中华医学会糖尿病学分会, 2021, [中华糖尿病杂志, Chinese Journal of Diabetes Mellitus], V13, P315
[8]  
Chinese Medical Association, 2020, CHIN J GEN PRACT, V19, P304, DOI [10.3760/cma.j.cn114798-20200117-00058, DOI 10.3760/CMA.J.CN114798-20200117-00058]
[9]   Glycemic control and fracture risk in elderly patients with diabetes [J].
Conway, Baqiyyah N. ;
Long, Dustin M. ;
Figaro, M. Kathleen ;
May, Michael E. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 115 :47-53
[10]   Vertebral fracture in postmenopausal Chinese women: a population-based study [J].
Cui, L. . ;
Chen, L. ;
Xia, W. ;
Jiang, Y. ;
Cui, L. ;
Huang, W. ;
Wang, W. ;
Wang, X. ;
Pei, Y. ;
Zheng, X. ;
Wang, Q. ;
Ning, Z. ;
Li, M. ;
Wang, O. ;
Xing, X. ;
Lin, Q. ;
Yu, W. ;
Weng, X. ;
Xu, L. ;
Cummings, S. R. .
OSTEOPOROSIS INTERNATIONAL, 2017, 28 (09) :2583-2590